ARQT Arcutis Biotherapeutics, Inc. - Common stock
$27,03
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 5, 2026
Zakres 52 tyg.
$15–$32
72% of range
Ocena Analityków
BUY
14 analysts
Cena Docelowa
$37
+36% upside
P/E (TTM)
-207.9
ROE
-9.8%
Marża Zysku Netto
-4.3%
ARQT Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$27.03
Kapitalizacja Rynkowa
$3.33B
P/E (TTM)
-207.9
EPS (TTM)
$-0.13
Przychody (TTM)
$376M
Stopa dywidendy
—
ROE
-9.8%
D/E Dług/Kapitał
0.6
Zakres 52 tyg.
$15 – $32
ARQT Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$376M
2020-12-31
→
2025-12-31
EPS
$-0.13
2019-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-6M
2020-12-31
→
2025-12-31
Marże
-4.3%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
ARQT
Mediana porównawcza
P/E (TTM)
-207.9
—
P/S (TTM)
8.9
18.3
P/B
17.6
3.3
EV / EBITDA
-278.1
—
Price / FCF (Cena / FCF)
-528.2
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
ARQT
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-3.2%
—
Net Profit Margin (Marża Zysku Netto)
-4.3%
-180.4%
ROA
-4.1%
-36.2%
ROE
-9.8%
-43.7%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
ARQT
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
0.6
—
Current Ratio (Wskaźnik bieżący)
3.2
9.7
Quick Ratio (Wskaźnik Szybkości)
1.5
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
ARQT
Mediana porównawcza
Revenue YoY (Przychody R/R)
91.3%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
367.3%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
ARQT
Mediana porównawcza
ARQT Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
14 analityków
- Mocne kupno 4 28,6%
- Kup 8 57,1%
- Trzymaj 2 14,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
8 analityków · 2026-08-13
Mediana
$37.00
← Poniżej wszystkich celów
$27.03
Niski
$34.00
Wysoki
$40.00
Średni cel
$37.00
+36,9%
Średnia cel
$36.88
+36,4%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.05%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $0.11 | $0.04 | 0.07% |
| 31 marca 2026 | $-0.09 | $-0.08 | -0.01% |
| 31 grudnia 2025 | $0.13 | $0.12 | 0.01% |
| 30 września 2025 | $0.06 | $-0.10 | 0.16% |
| 30 czerwca 2025 | $-0.13 | $-0.16 | 0.03% |
| 31 marca 2025 | $-0.20 | $-0.21 | 0.01% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $376M | $197M | $60M | $4M | $0 | $0 | |
| Cost of Revenue | $37M | $19M | $5M | $754.0K | $0 | · | |
| R&D Expense | $77M | $76M | $111M | $182M | $146M | $115M | |
| SG&A Expense | $275M | $229M | $185M | $122M | $61M | $21M | |
| Operating Expenses | $388M | $325M | $301M | $305M | $207M | $137M | |
| Operating Income | $-12M | $-128M | $-241M | $-302M | $-207M | $-137M | |
| Interest Expense | · | · | $30M | $16M | $0 | $0 | |
| Other Non-op | $443.0K | $47.0K | $-731.0K | $6M | $173.0K | $967.0K | |
| Income Tax | $1M | $647.0K | $3M | $0 | $0 | $0 | |
| Net Income | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| EPS (Basic) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| EPS (Diluted) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| Shares (Basic) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| Shares (Diluted) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| EBITDA | $-12M | $-128M | $-241M | · | · | $-137M |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $71M | $88M | $54M | $96M | $65M | |
| Receivables | $146M | $73M | $26M | $8M | $0 | · | |
| Inventory | $23M | $15M | $13M | $8M | $0 | · | |
| Prepaid Expense | $21M | $20M | $19M | $11M | $14M | $7M | |
| Current Assets | $411M | $336M | $330M | $437M | $403M | $293M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | $532.0K | $78.0K | |
| Intangibles | $15M | $9M | $6M | $7M | $0 | · | |
| Other Non-current Assets | $1M | $596.0K | $596.0K | $78.0K | $78.0K | $78.0K | |
| Total Assets | $433M | $349M | $341M | $449M | $408M | $298M | |
| Accounts Payable | $13M | $14M | $12M | $9M | $7M | $7M | |
| Accrued Liabilities | $116M | $67M | $34M | $28M | $26M | $15M | |
| Current Liabilities | $130M | $81M | $47M | $38M | $33M | $23M | |
| Capital Leases | $5M | $3M | $3M | $4M | $5M | $5M | |
| Other Non-current Liabilities | $431.0K | $570.0K | $849.0K | $0 | $25.0K | $82.0K | |
| Total Liabilities | $243M | $191M | $253M | $240M | $110M | $28M | |
| Long-term Debt | $109M | $107M | $202M | $198M | $72M | $0 | |
| Total Debt | $109M | $107M | $202M | · | · | · | |
| Common Stock | $12.0K | $12.0K | $9.0K | $6.0K | $5.0K | $4.0K | |
| Paid-in Capital | $1.33B | $1.28B | $1.07B | $930M | $706M | $473M | |
| Retained Earnings | $-1.14B | $-1.12B | $-982M | $-720M | $-408M | $-202M | |
| AOCI | $-44.0K | $-7.0K | $4.0K | $-1M | $-255.0K | $-2.0K | |
| Stockholders' Equity | $189M | $158M | $89M | $210M | $298M | $271M | |
| Liabilities + Equity | $433M | $349M | $341M | $449M | $408M | $298M | |
| Shares Outstanding | 123,333,000 | 117,848,033 | 96,787,343 | 61,037,403 | 50,255,614 | 43,338,438 |
Przepływy pieniężne 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $42M | $39M | $33M | $24M | $8M | |
| Deferred Tax | $54.0K | $-152.0K | $0 | $0 | $0 | · | |
| Amort. of Intangibles | $5M | $2M | $750.0K | $312.0K | $0 | $0 | |
| Operating Cash Flow | $-6M | $-112M | $-247M | $-258M | $-175M | $-113M | |
| CapEx | $686.0K | $143.0K | $428.0K | $333.0K | $995.0K | $321.0K | |
| Investing Cash Flow | $-30M | $29M | $180M | $-87M | $-76M | $-182M | |
| Debt Issued | · | $0 | $0 | $125M | $74M | $0 | |
| Net Debt Issued | $0 | $-100M | $0 | · | · | · | |
| Stock Issued | $0 | $162M | $0 | $162M | $207M | $128M | |
| Net Stock Activity | $0 | $162M | $0 | · | · | $128M | |
| Financing Cash Flow | $7M | $66M | $101M | $302M | $282M | $298M | |
| Net Change in Cash | $-29M | $-17M | $34M | $-43M | $31M | $3M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | |
| Free Cash Flow | $-6M | $-112M | $-247M | · | · | $-113M |
Rentowność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| Net Margin | -4.3% | -71.2% | -439.8% | · | · | · | |
| EBITDA Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| ROA | -4.1% | -40.6% | -66.3% | · | · | -67.0% | |
| ROE | -9.8% | -89.1% | -387.2% | · | · | -61.2% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 4.1 | 7.1 | · | · | 13.0 | |
| Quick Ratio | 1.5 | 1.8 | 2.4 | · | · | 2.9 | |
| Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| LT Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| Interest Coverage | · | · | -8.1 | · | · | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.2 | · | · | · | |
| Inventory Turnover | 2.0 | 1.4 | 0.5 | · | · | · | |
| Receivables Turnover | 3.4 | 4.0 | 3.5 | · | · | · |
Stopy Wzrostu 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 91.3% | 229.7% | 1517.1% | · | · | · | |
| Revenue CAGR 3Y | 367.3% | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $376M | $197M | $60M | $4M | $0 | $0 | |
| Net Income TTM | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| Market Cap | $3.58B | $1.64B | $313M | · | · | $1.22B | |
| Enterprise Value | $3.65B | $1.68B | $426M | · | · | · | |
| P/E | -223.4 | -12.0 | -0.9 | -2.6 | -5.0 | -7.4 | |
| P/S | 9.5 | 8.4 | 5.2 | · | · | · | |
| P/B | 18.9 | 10.4 | 3.5 | · | · | 4.5 | |
| P / Tangible Book | 20.5 | 11.1 | 3.8 | 4.5 | 3.5 | 4.5 | |
| P / Cash Flow | -636.7 | -14.6 | -1.3 | · | · | -10.8 | |
| P / FCF | -567.5 | -14.6 | -1.3 | · | · | -10.8 | |
| EV / EBITDA | -298.3 | -13.1 | -1.8 | · | · | · | |
| EV / FCF | -578.0 | -14.9 | -1.7 | · | · | · | |
| EV / Revenue | 9.7 | 8.5 | 7.1 | · | · | · | |
| Earnings Yield | -0.45% | -8.3% | -117.0% | -38.2% | -20.2% | -13.5% |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $130M | $105M | $130M | $99M | $82M | $66M | $71M | $45M | $31M | $50M | $14M | $38M | $5M | $3M | $3M | $725.0K | |
| Cost of Revenue | $11M | $10M | $12M | $9M | $7M | $9M | $7M | $6M | $3M | $3M | $2M | $1M | $776.0K | $783.0K | · | · | |
| R&D Expense | $20M | $31M | $20M | $20M | $19M | $18M | $14M | $20M | $19M | $23M | $24M | $26M | $25M | $35M | $34M | $70M | |
| SG&A Expense | $82M | $74M | $79M | $62M | $69M | $64M | $58M | $59M | $58M | $55M | $49M | $48M | $46M | $43M | $37M | $35M | |
| Operating Expenses | $113M | $114M | $111M | $91M | $96M | $90M | $79M | $84M | $81M | $81M | $75M | $75M | $72M | $79M | $71M | $105M | |
| Operating Income | $16M | $-9M | $18M | $9M | $-15M | $-25M | $-8M | $-39M | $-50M | $-32M | $-61M | $-37M | $-67M | $-76M | $-68M | $-105M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | · | $8M | $7M | $7M | · | $5M | |
| Interest Income | $2M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-157.0K | $-20.0K | $-6M | $2M | $20.0K | $193.0K | $-13M | $4M | $5M | $4M | $-10M | $3M | $3M | $3M | $3M | $2M | |
| Income Tax | $136.0K | $93.0K | $470.0K | $80.0K | $342.0K | $279.0K | $323.0K | $0 | $0 | $324.0K | $90.0K | $3M | $0 | $0 | $0 | $0 | |
| Net Income | $15M | $-11M | $17M | $7M | $-16M | $-25M | $-11M | $-42M | $-52M | $-35M | $-66M | $-45M | $-71M | $-80M | $-72M | $-108M | |
| EPS (Basic) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| EPS (Diluted) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| Shares (Basic) | 130,522,000 | 129,365 | -253,422,862 | 127,623,000 | 126,997,000 | 126,037 | -237,873,525 | 124,302,000 | 123,481,000 | 111,048,525 | -115,021,987 | 61,727,278 | 61,430,620 | 61,169,089 | -103,995,388 | 57,091,743 | |
| Shares (Diluted) | 135,898,000 | 129,365 | -258,684,862 | 132,885,000 | 126,997,000 | 126,037 | -237,873,525 | 124,302,000 | 123,481,000 | 111,048,525 | -115,021,987 | 61,727,278 | 61,430,620 | 61,169,089 | -103,995,388 | 57,091,743 | |
| EBITDA | $16M | $-9M | · | $9M | $-15M | $-25M | · | $-39M | $-50M | · | · | $-37M | · | · | · | $-105M |
Bilans 26
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $35M | $43M | $47M | $73M | $53M | $71M | $135M | $84M | $190M | · | $107M | $105M | $81M | · | $82M | |
| Receivables | $155M | $144M | $146M | $115M | $107M | $85M | $73M | $60M | $43M | $37M | · | $19M | $17M | $13M | · | $2M | |
| Inventory | $39M | $37M | $23M | $22M | $16M | $17M | $15M | $14M | $14M | $13M | · | $14M | $10M | $9M | · | $4M | |
| Prepaid Expense | $35M | $32M | $21M | $20M | $19M | $23M | $20M | $18M | $14M | $13M | · | $20M | $12M | $13M | · | $12M | |
| Current Assets | $468M | $438M | $411M | $349M | $333M | $324M | $336M | $424M | $435M | $468M | · | $282M | $309M | $368M | · | $497M | |
| PP&E (Net) | $872.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| PP&E (Gross) | · | · | $4M | · | · | · | $4M | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | · | · | · | · | $2M | $2M | $1M | · | $993.0K | |
| Intangibles | $14M | $14M | $15M | $15M | $16M | $16M | $9M | $10M | $6M | $6M | · | $7M | $7M | $7M | · | $7M | |
| Other Non-current Assets | $2M | $2M | $1M | $596.0K | $596.0K | $596.0K | $596.0K | $596.0K | $595.0K | $596.0K | · | $596.0K | $596.0K | $78.0K | · | $78.0K | |
| Total Assets | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Accounts Payable | $7M | $18M | $13M | $6M | $15M | $25M | $14M | $19M | $8M | $13M | · | $13M | $17M | $12M | · | $9M | |
| Accrued Liabilities | $147M | $137M | $116M | $93M | $88M | $66M | $67M | $53M | $43M | $34M | · | $28M | $19M | $24M | · | $28M | |
| Current Liabilities | $160M | $163M | $130M | $100M | $104M | $91M | $81M | $172M | $51M | $47M | · | $42M | $37M | $37M | · | $37M | |
| Capital Leases | $5M | $5M | $5M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $4M | |
| Other Non-current Liabilities | $431.0K | $431.0K | $431.0K | $360.0K | $360.0K | $360.0K | $570.0K | $420.0K | $194.0K | $306.0K | · | · | · | · | · | $0 | |
| Total Liabilities | $268M | $270M | $243M | $213M | $213M | $201M | $191M | $281M | $258M | $254M | · | $246M | $240M | $240M | · | $238M | |
| Long-term Debt | $109M | $109M | $109M | $108M | $108M | $108M | $107M | $205M | $204M | $203M | · | $201M | $200M | $199M | · | $197M | |
| Total Debt | $109M | $109M | · | $108M | $108M | $108M | · | $205M | $204M | · | · | $201M | · | · | · | $197M | |
| Common Stock | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $1.36B | $1.34B | $1.33B | $1.31B | $1.30B | $1.29B | $1.28B | $1.27B | $1.26B | $1.24B | · | $963M | $952M | $940M | · | $920M | |
| Retained Earnings | $-1.13B | $-1.15B | $-1.14B | $-1.16B | $-1.16B | $-1.15B | $-1.12B | $-1.11B | $-1.07B | $-1.02B | · | $-916M | $-871M | $-800M | · | $-648M | |
| AOCI | $-656.0K | $-514.0K | $-44.0K | $-62.0K | $-35.0K | $-140.0K | $-7.0K | $533.0K | $-294.0K | $-133.0K | · | $-184.0K | $-292.0K | $-414.0K | · | $-2M | |
| Stockholders' Equity | $221M | $190M | $189M | $158M | $139M | $143M | $158M | $157M | $186M | $225M | $89M | $47M | $81M | $140M | $210M | $271M | |
| Liabilities + Equity | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Shares Outstanding | 125,591,000 | 125,042,000 | 123,332,672 | 120,288,146 | 119,797,738 | 119,137,785 | 117,848,033 | 116,998,829 | 116,480,267 | 115,505,437 | · | 61,858,044 | 61,630,018 | 61,357,932 | · | 60,908,641 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $11M | $10M | $10M | $10M | $10M | $9M | $10M | $13M | $10M | $9M | $10M | $11M | $9M | $9M | $9M | |
| Amort. of Intangibles | $563.0K | $562.0K | $563.0K | $562.0K | $563.0K | $3M | $313.0K | $1M | $200.0K | $188.0K | $-188M | $188M | $200.0K | $188.0K | $187.0K | $125.0K | |
| Operating Cash Flow | $13M | $2M | $26M | $-2M | $324.0K | $-30M | $-748.0K | $-35M | $-45M | $-32M | $-56M | $-44M | $-66M | $-80M | $-71M | $-68M | |
| CapEx | $158.0K | $0 | $0 | $0 | $78.0K | $608.0K | $0 | $143.0K | $0 | $0 | $6.0K | $64.0K | $276.0K | $82.0K | $123.0K | $6.0K | |
| Investing Cash Flow | $-15M | $-11M | $-34M | $-25M | $17M | $12M | $35M | $85M | $-62M | $-29M | $-62M | $46M | $89M | $108M | $42M | $-197M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $162M | $0 | $0 | $0 | $0 | $0 | $162M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $1M | $4M | $1M | $1M | $395.0K | $-97M | $394.0K | $1M | $162M | $99M | $867.0K | $1M | $100.0K | $962.0K | $285M | |
| Net Change in Cash | $-641.0K | $-8M | $-4M | $-26M | $19M | $-18M | $-64M | $51M | $-106M | $101M | $-19M | $2M | $24M | $27M | $-28M | $20M | |
| Free Cash Flow | · | $2M | · | · | · | $-31M | · | · | · | · | · | · | · | · | · | · |
Rentowność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| Net Margin | 11.6% | -10.7% | · | 7.5% | -19.5% | -38.1% | · | -92.8% | -169.6% | · | · | -117.5% | · | · | · | -14856.4% | |
| EBITDA Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| ROA | 3.6% | -2.8% | · | 1.8% | -4.0% | -6.1% | · | -11.4% | -13.7% | · | · | -11.2% | · | · | · | -24.0% | |
| ROE | 8.3% | -6.8% | · | 4.7% | -9.8% | -13.6% | · | -40.8% | -39.2% | · | · | -28.2% | · | · | · | -34.0% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.7 | · | 3.5 | 3.2 | 3.6 | · | 2.5 | 8.5 | · | · | 6.7 | · | · | · | 13.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.6 | 1.7 | 1.5 | · | 1.1 | 2.5 | · | · | 3.0 | · | · | · | 2.3 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.7 | 0.8 | 0.8 | · | 1.3 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.7 | 0.8 | 0.8 | · | 0.7 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -4.9 | · | · | · | -21.4 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | · | · | 0.1 | · | · | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.6 | · | 0.4 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.0 | 0.9 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.0 | · | · | 3.5 | · | · | · | 0.6 |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $416M | $352M | · | $291M | $223M | $191M | · | $163M | $124M | $96M | · | $47M | $9M | $4M | · | $725.0K | |
| Net Income TTM | $-5M | $-45M | · | $-75M | $-135M | $-154M | · | $-174M | $-203M | $-231M | · | $-304M | $-326M | $-320M | · | $-296M | |
| Market Cap | $3.29B | $2.95B | · | $2.27B | $1.68B | $1.86B | · | $1.09B | $1.08B | · | · | $328M | · | · | · | $1.16B | |
| Enterprise Value | $3.37B | $3.02B | · | $2.33B | $1.71B | $1.92B | · | $1.16B | $1.20B | · | · | $422M | · | · | · | $1.28B | |
| P/E | -524.4 | -65.4 | · | -31.4 | -13.0 | -12.3 | · | -5.2 | -3.5 | -2.8 | · | -1.0 | -1.7 | -1.9 | · | -3.4 | |
| P/S | 7.9 | 8.4 | · | 7.8 | 7.5 | 9.8 | · | 6.7 | 8.8 | · | · | 7.0 | · | · | · | 1605.5 | |
| P/B | 14.9 | 15.5 | · | 14.3 | 12.1 | 13.1 | · | 6.9 | 5.8 | · | · | 7.0 | · | · | · | 4.3 | |
| P / Tangible Book | 15.9 | 16.8 | · | 15.9 | 13.7 | 14.8 | · | 7.4 | 6.0 | 5.2 | · | 8.2 | 8.0 | 5.1 | · | 4.4 | |
| P / Cash Flow | · | 1315.8 | · | · | · | -61.3 | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | · | 1315.8 | · | · | · | -60.1 | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 205.0 | -332.3 | · | 273.1 | -117.4 | -78.2 | · | -29.6 | -24.0 | · | · | -11.4 | · | · | · | -12.2 | |
| EV / FCF | · | 1349.1 | · | · | · | -61.9 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 8.1 | 8.6 | · | 8.0 | 7.7 | 10.0 | · | 7.1 | 9.7 | · | · | 9.0 | · | · | · | 1764.4 | |
| Earnings Yield | -0.19% | -1.5% | · | -3.2% | -7.7% | -8.1% | · | -19.4% | -28.3% | -35.5% | · | -95.9% | -59.5% | -52.5% | · | -29.4% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $376M | $197M | $60M | $4M | $0 |
| Marża Operacyjna % | -3.2% | -65.3% | -404.5% | — | — |
| Zysk netto | $-16M | $-140M | $-262M | $-311M | $-206M |
| Rozwodniony EPS | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.6 | 0.7 | 2.3 | — | — |
| Wskaźnik bieżący | 3.2 | 4.1 | 7.1 | — | — |
| Wskaźnik Szybkości | 1.5 | 1.8 | 2.4 | — | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-6M | $-112M | $-247M | — | — |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 292 emitenci · $2.6B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 47 (+10 vs poprzedni kw.) | 33 (-9 vs poprzedni kw.) | 90 (-8 vs poprzedni kw.) | 96 (+4 vs poprzedni kw.) | +5.9M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $326 098 140 | 12 437 000 | 12,35% | Akcje |
| Frazier Life Sciences Management, L.P. | $258 909 678 | 9 874 511 | 9,80% | Akcje |
| Rubric Capital Management LP | $216 880 749 | 8 271 577 | 8,21% | Akcje |
| Polar Capital Holdings Plc | $173 234 098 | 6 606 945 | 6,56% | Akcje |
| STATE STREET CORP | $152 674 865 | 5 822 840 | 5,78% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $130 805 182 | 4 988 756 | 4,95% | Akcje |
| JENNISON ASSOCIATES LLC | $86 505 943 | 3 299 235 | 3,28% | Akcje |
| D. E. Shaw & Co., Inc. | $81 220 383 | 3 097 650 | 3,08% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $67 179 379 | 2 561 595 | 2,54% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $63 688 511 | 2 429 005 | 2,41% | Akcje |
| ORBIMED ADVISORS LLC | $53 541 240 | 2 042 000 | 2,03% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $50 474 363 | 1 925 031 | 1,91% | Akcje |
| JANUS HENDERSON GROUP PLC | $42 621 972 | 1 809 466 | 1,61% | Akcje |
| OBERWEIS ASSET MANAGEMENT INC/ | $35 998 513 | 1 372 941 | 1,36% | Akcje |
| GILDER GAGNON HOWE & CO LLC | $34 432 392 | 1 313 211 | 1,30% | Akcje |
| Pivotal bioVenture Partners Investment Advisor LLC | $33 175 720 | 1 265 283 | 1,26% | Akcje |
| BANK OF AMERICA CORP /DE/ | $33 121 130 | 1 263 201 | 1,25% | Akcje |
| BAMCO INC /NY/ | $32 856 806 | 1 253 120 | 1,24% | Akcje |
| CITADEL ADVISORS LLC | $29 766 543 | 1 135 261 | 1,13% | Akcje |
| Aberdeen Group plc | $28 635 465 | 1 092 123 | 1,08% | Akcje |
| Jones Hill Capital LP | $28 571 960 | 1 089 701 | 1,08% | Akcje |
| GOLDMAN SACHS GROUP INC | $28 558 011 | 1 089 169 | 1,08% | Akcje |
| Perpetual Ltd | $27 642 802 | 1 054 264 | 1,05% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $27 555 489 | 1 050 934 | 1,04% | Akcje |
| Ensign Peak Advisors, Inc | $25 552 281 | 974 534 | 0,97% | Akcje |
| Candriam S.C.A. | $24 880 817 | 949 839 | 0,94% | Akcje |
| Driehaus Capital Management LLC | $23 032 330 | 878 426 | 0,87% | Akcje |
| VANGUARD GROUP INC | $22 159 001 | 763 051 | 0,84% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $21 372 918 | 815 138 | 0,81% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $21 284 137 | 811 752 | 0,81% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $17 406 855 | 663 877 | 0,66% | Akcje |
| FISHMAN JAY A LTD/MI | $15 601 031 | 595 005 | 0,59% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $14 789 968 | 564 072 | 0,56% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $14 349 629 | 547 278 | 0,54% | Akcje |
| Squarepoint Ops LLC | $14 099 726 | 537 747 | 0,53% | Akcje |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $13 110 000 | 500 000 | 0,50% | Akcje |
| Nearwater Capital Markets, Ltd | $12 761 274 | 486 700 | 0,48% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12 218 520 | 466 000 | 0,46% | Akcje |
| Privium Fund Management B.V. | $10 471 403 | 399 367 | 0,40% | Akcje |
| NORGES BANK | $10 286 106 | 392 300 | 0,39% | Akcje |
| Patient Square Capital LP | $9 701 400 | 370 000 | 0,37% | Akcje |
| Point72 Asset Management, L.P. | $9 503 413 | 362 449 | 0,36% | Akcje |
| Qube Research & Technologies Ltd | $9 482 778 | 361 662 | 0,36% | Akcje |
| Longaeva Partners L.P. | $9 040 551 | 344 796 | 0,34% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8 741 748 | 333 400 | 0,33% | Opcja kupna |
| FMR LLC | $8 001 453 | 305 166 | 0,30% | Akcje |
| PEREGRINE CAPITAL MANAGEMENT LLC | $7 641 740 | 291 447 | 0,29% | Akcje |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $7 467 168 | 284 789 | 0,28% | Akcje |
| FIRST TRUST ADVISORS LP | $7 448 184 | 284 065 | 0,28% | Akcje |
| AMERIPRISE FINANCIAL INC | $7 133 676 | 272 070 | 0,27% | Akcje |
| Walleye Capital LLC | $6 818 065 | 260 033 | 0,26% | Akcje |
| Balyasny Asset Management L.P. | $6 374 580 | 243 119 | 0,24% | Akcje |
| PFM Health Sciences, LP | $6 347 049 | 242 069 | 0,24% | Akcje |
| MYDA Advisors LLC | $6 292 800 | 240 000 | 0,24% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $6 054 329 | 230 905 | 0,23% | Akcje |
| Swiss National Bank | $5 873 280 | 224 000 | 0,22% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5 763 549 | 219 815 | 0,22% | Akcje |
| Pictet Asset Management Holding SA | $5 350 188 | 200 275 | 0,20% | Akcje |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $5 235 688 | 199 683 | 0,20% | Akcje |
| Woodline Partners LP | $5 113 765 | 195 033 | 0,19% | Akcje |
| BlackRock, Inc. | $4 724 084 | 180 171 | 0,18% | Akcje |
| Cormorant Asset Management, LP | $4 588 500 | 175 000 | 0,17% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $4 586 166 | 174 911 | 0,17% | Akcje |
| TWO SIGMA ADVISERS, LP | $4 533 144 | 156 100 | 0,17% | Akcje |
| RHUMBLINE ADVISERS | $4 471 596 | 170 542 | 0,17% | Akcje |
| Holocene Advisors, LP | $4 293 053 | 163 732 | 0,16% | Akcje |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $4 127 788 | 157 429 | 0,16% | Akcje |
| PDT Partners, LLC | $4 066 067 | 155 075 | 0,15% | Akcje |
| CITIGROUP INC | $3 796 394 | 144 790 | 0,14% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $3 616 499 | 137 929 | 0,14% | Akcje |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $3 605 250 | 137 500 | 0,14% | Akcje |
| CASTLEARK MANAGEMENT LLC | $3 603 152 | 137 420 | 0,14% | Akcje |
| Eversept Partners, LP | $3 549 008 | 135 355 | 0,13% | Akcje |
| LAZARD ASSET MANAGEMENT LLC | $3 491 088 | 133 146 | 0,13% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $3 458 785 | 131 914 | 0,13% | Akcje |
| MORGAN STANLEY | $3 424 175 | 130 594 | 0,13% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $3 213 419 | 136 393 | 0,12% | Akcje |
| JANE STREET GROUP, LLC | $3 088 716 | 117 800 | 0,12% | Opcja kupna |
| 1492 Capital Management LLC | $3 047 052 | 116 211 | 0,12% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3 023 149 | 128 317 | 0,11% | Akcje |
| Tejara Capital Ltd | $2 965 062 | 113 084 | 0,11% | Akcje |
| LPL Financial LLC | $2 914 353 | 111 150 | 0,11% | Akcje |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2 776 671 | 103 762 | 0,11% | Akcje |
| STEMPOINT CAPITAL LP | $2 594 338 | 98 945 | 0,10% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2 496 000 | 95 197 | 0,09% | Akcje |
| CITADEL ADVISORS LLC | $2 480 412 | 94 600 | 0,09% | Opcja kupna |
| Aquatic Capital Management LLC | $2 258 329 | 86 130 | 0,09% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2 255 628 | 86 027 | 0,09% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $2 135 488 | 81 445 | 0,08% | Akcje |
| WESBANCO BANK INC | $2 126 442 | 81 100 | 0,08% | Akcje |
| Rafferty Asset Management, LLC | $2 117 973 | 80 777 | 0,08% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $1 981 498 | 75 572 | 0,08% | Akcje |
| JUPITER ASSET MANAGEMENT LTD | $1 980 685 | 75 541 | 0,07% | Akcje |
| Erste Asset Management GmbH | $1 956 156 | 73 100 | 0,07% | Akcje |
| FEDERATED HERMES, INC. | $1 952 315 | 74 459 | 0,07% | Akcje |
| Jain Global LLC | $1 917 757 | 73 141 | 0,07% | Akcje |
| Vontobel Holding Ltd. | $1 789 305 | 68 242 | 0,07% | Akcje |
| MetLife Investment Management, LLC | $1 747 012 | 66 629 | 0,07% | Akcje |
| Focus Partners Wealth | $1 651 363 | 62 981 | 0,06% | Akcje |
| CenterBook Partners LP | $1 597 925 | 60 943 | 0,06% | Akcje |
Insiderzy spółki 18 insiderów · 2 dyrektorzy generalni · 12 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Scott L Burrows | Chief Financial Officer | 27 grudnia 2021 S | 22 679 | 0 | 0 | $0 |
| David W Osborne | Chief Technical Officer | 4 lutego 2020 C | 270 279 | 0 | 0 | $0 |
| Howard G. Welgus | Dyrektor | 15 lipca 2026 M | 37 109 | 0 | 3 | $-243 567 |
| Christopher Peetz | Dyrektor | 15 lipca 2026 A | 4 315 | 0 | 0 | $0 |
| Sue-Jean Lin | Dyrektor | 15 czerwca 2026 S | 27 567 | 0 | 1 | $-120 583 |
| Neha Krishnamohan | Dyrektor | 5 czerwca 2026 A | 27 901 | 0 | 0 | $0 |
| Terrie Curran | Dyrektor | 5 czerwca 2026 A | 23 526 | 0 | 0 | $0 |
| Amit Munshi | Dyrektor | 5 czerwca 2026 A | 9 799 | 0 | 0 | $0 |
| Halley E Gilbert | Dyrektor | 5 czerwca 2026 A | 27 901 | 0 | 0 | $0 |
| Keith R Leonard | Dyrektor | 5 czerwca 2026 A | 27 901 | 0 | 0 | $0 |
| Patrick J. Heron | Dyrektor | 5 czerwca 2026 A | 32 213 | 0 | 0 | $0 |
| Jonathan Silverstein | Dyrektor | 2 października 2020 P | 902 286 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | Dyrektor | 4 lutego 2020 C | 49 981 | 0 | 0 | $0 |
| Joseph L Turner | Dyrektor | 30 stycznia 2020 A | — | 0 | 0 | $0 |
| Patrick Burnett | — | 12 sierpnia 2026 M | 119 289 | 0 | 3 | $-419 797 |
| Todd Franklin Watanabe | — | 3 sierpnia 2026 S | 717 203 | 0 | 1 | $-114 275 |
| Masaru Matsuda | — | 3 sierpnia 2026 S | 126 171 | 0 | 1 | $-32 128 |
| Ricky Sun | — | 9 czerwca 2021 A | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 3 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P., FHM LIFE SCIENCES VIII, L.P., FHM LIFE SCIENCES VIII, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×8 zgłoszenia | 20 sierpnia 2025 | 7,50% | Aneks | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Capital LLC ×7 zgłoszenia | 26 sierpnia 2022 | — | Pierwotne zgłoszenie | — | SEC |
| Bain Capital Life Sciences Fund, L.P., BCIP Life Sciences Associates, LP ×4 zgłoszenia | 8 sierpnia 2022 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 45 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1,38% | 134 950 SH | 8 sierpnia 2026 | Dziennie |
| BBP · ETFis Series Trust I | 1,28% | 32 610 NS | 30 kwietnia 2026 | N-PORT |
| GURU · Global X Funds | 0,95% | 23 918 NS | 30 kwietnia 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,88% | 196 991 NS | 30 kwietnia 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,54% | 70 043 NS | 31 maja 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,36% | 64 844 SH | 8 sierpnia 2026 | Dziennie |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,32% | 145 888 NS | 30 kwietnia 2026 | N-PORT |
| IBB · iShares Trust | 0,23% | 812 141 SH | 8 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,22% | 6 809 SH | 8 sierpnia 2026 | Dziennie |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,20% | 9 018 NS | 31 maja 2026 | N-PORT |
| IWO · iShares Trust | 0,19% | 1 035 865 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,18% | 122 691 SH | 8 sierpnia 2026 | Dziennie |
| OASC · Unified Series Trust | 0,17% | 6 744 NS | 31 maja 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,17% | 88 401 NS | 30 kwietnia 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,16% | 74 441 NS | 31 maja 2026 | N-PORT |
| BIB · ProShares Trust | 0,13% | 4 587 NS | 31 maja 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 41 766 NS | 30 kwietnia 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,11% | 3 711 NS | 30 kwietnia 2026 | N-PORT |
| IWM · iShares Trust | 0,09% | 2 886 529 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 658 480 SH | 8 sierpnia 2026 | Dziennie |
| ISCG · iShares Trust | 0,09% | 33 974 SH | 8 sierpnia 2026 | Dziennie |
| ESML · iShares Trust | 0,08% | 85 491 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,08% | 47 709 NS | 30 kwietnia 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,07% | 55 080 SH | 8 sierpnia 2026 | Dziennie |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 13 604 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 5 179 NS | 31 maja 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 534 058 NS | 31 maja 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 5 598 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 51 951 SH | 8 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | 0,04% | 4 781 SH | 8 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 50 560 NS | 30 kwietnia 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,04% | 335 913 SH | 8 sierpnia 2026 | Dziennie |
| UWM · ProShares Trust | 0,03% | 4 051 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1 307 970 SH | 8 sierpnia 2026 | Dziennie |
| URTY · ProShares Trust | 0,03% | 4 104 NS | 31 maja 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 6 296 SH | 8 sierpnia 2026 | Dziennie |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 4 427 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 103 NS | 31 maja 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 33 557 NS | 31 maja 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 152 941 SH | 8 sierpnia 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 31 312 SH | 8 sierpnia 2026 | Dziennie |
| TILT · FlexShares Trust | 0,00% | 3 054 NS | 30 kwietnia 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 64 126 NS | 31 maja 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3 565 928 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9 521 SH | 8 sierpnia 2026 | Dziennie |